Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expression of Aberrant CD Markers in Acute Leukemia:Retrospective Study in South Egypt Cancer Institute

NCT03743909 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03743909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03743909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expression of Aberrant CD Markers in Acute Leukemia:Retrospective Study in South Egypt Cancer Institute
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2019
Completion date
April 30, 2021
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia